Geoffrey MacKay's Net Worth
$2.02 Million
Who is Geoffrey MacKay?
Geoffrey MacKay has an estimated net worth of $2.02 Million. This is based on reported shares across multiple companies, which include Talaris Therapeutics, Inc., and AVROBIO, Inc..
SEC CIK
Geoffrey MacKay's CIK is 0001741849
Past Insider Trading and Trends
2022 was Geoffrey MacKay's most active year for acquiring shares with 5 total transactions. Geoffrey MacKay's most active month to acquire stocks was the month of January. 2020 was Geoffrey MacKay's most active year for disposing of shares, totalling 4 transactions. Geoffrey MacKay's most active month to dispose stocks was the month of January. 2022 saw Geoffrey MacKay paying a total of $58,679.77 for 1,278,014 shares, this is the most they've acquired in one year. In 2020 Geoffrey MacKay cashed out on 164,400 shares for a total of $1,777,772.56, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Talaris Therapeutics, Inc. (TRML) Snapshot price: $16.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVROBIO, Inc. (AVRO) No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| +7.83% | 46K |
$0.91 | $41,859.09 | 633.13K |
Dec 28 - Jan 24
| |||
Form 4
| +57.94% | 142.01K |
$0.41 | $58,679.77 | 387.14K |
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +68.91% | 100K |
$0.41 | $41,320.00 | 245.12K |
Dec 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
| -0.40% | -1.40K |
$29.07 | -$40,691.98 | 345.12K |
Scheduled
|
Feb 12
| ||
Form 4
| -15.38% | -63.00K |
$27.57 | -$1,737,080.58 | 346.52K |
Scheduled
|
Feb 11
| ||
Form 4
| -3.31% | -14.00K |
$27.25 | -$381,511.10 | 409.52K |
Scheduled
|
Apr 5 - Apr 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||